Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 10/20 | 0.41 |
| ▸ | OGFRL1 | Q5TC84 | 10/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 9/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 9/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28819623 | 0.91 | MCHR1 (0.44) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| Hydrochloric Acid SCHEMBL28819554 | 0.88 | OGFRL1 (0.45) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819591 | 0.85 | MCHR1 (0.44) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819719 | 0.85 | OGFRL1 (0.40) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819661 | 0.84 | CHEK2 (0.48) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819495 | 0.84 | MCHR1 (0.44) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819669 | 0.84 | MCHR1 (0.43) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819743 | 0.84 | OPRM1 (0.41) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| Hydrochloric Acid SCHEMBL4208440 | 0.84 | CA1 (0.50) | OPRM1OGFRL1OPRD1OPRK1NR1H4 | |
| SCHEMBL28819704 | 0.84 | NR1H4 (0.54) | OPRM1OGFRL1OPRD1OPRK1NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110404073-B | Methods and pharmaceutical compositions for treating hepatitis B virus infection | 国家医疗保健研究所 | 2022-08-16 | — | — | CN | disclosed |